Publication:
Metabolically reprograming pancreatic stellate cells using a novel nanomedicine for the treatment of pancreatic cancer

dc.contributor.coauthorSharbeen, G.
dc.contributor.coauthorAkerman, A.
dc.contributor.coauthorMcCarroll, J.
dc.contributor.coauthorBoyer, C.
dc.contributor.coauthorHolst, J.
dc.contributor.coauthorYoukhana, J.
dc.contributor.coauthorDavis, T. P.
dc.contributor.coauthorGoldstein, D.
dc.contributor.coauthorPhillips, P. A.
dc.contributor.kuauthorErkan, Murat Mert
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid214689
dc.date.accessioned2024-11-09T23:52:43Z
dc.date.issued2018
dc.description.abstractN/A
dc.description.indexedbyWoS
dc.description.issue10
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.volume47
dc.identifier.doiN/A
dc.identifier.eissn1536-4828
dc.identifier.issn0885-3177
dc.identifier.quartileQ3
dc.identifier.urihttps://hdl.handle.net/20.500.14288/14879
dc.identifier.wos449304600230
dc.keywordsMetabolically reprograming
dc.keywordsPancreatic stellate cells
dc.keywordsNanomedicine
dc.keywordsPancreatic cancer
dc.languageEnglish
dc.publisherLippincott Williams and Wilkins (LWW)
dc.sourcePancreas
dc.subjectGastroenterology
dc.subjectHepatology
dc.titleMetabolically reprograming pancreatic stellate cells using a novel nanomedicine for the treatment of pancreatic cancer
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.authorid0000-0002-2753-0234
local.contributor.kuauthorErkan, Murat Mert

Files